JFL Life Sciences Limited files Prospectus with NSE EMERGE

New Delhi (India), August 18: JFL Life Sciences Limited, engaged in the business of manufacturing pharmaceutical products having an experience for more than a decade, has filed the prospectus with NSE EMERGE to raise Rs 1,816.58 Lakhs through an initial public offering (IPO).

The public issue of JFL Life Sciences Limited is for 29,78,000 equity shares of Face Value ₹10 each (“EQUITY SHARES”) for cash at a price of ₹ 61/- per equity share (including a securities premium of ₹ 51/- per equity share) (the issue price) aggregating ₹ 1,816.58 LACS of the issue. 1,50,000 equity shares aggregating to ₹ 91.50 Lakhs will be reserved for market maker (“Market Maker Reservation Portion”). The issue, less the Market Maker Reservation Portion, i.e., issue of 28,28,000 equity shares of Face Value of ₹ 10/- EACH at an issue price of ₹ 61/- per equity share, aggregating to ₹ 1,725.08 Lakhs, which is hereinafter referred to as “The Net Issue”. The issue and the Net Issue will constitute 27.08% AND 25.71%, respectively of the post issue paid up equity share capital of the company. The company will list at NSE Emerge. The Lead manager of the issue is GYR Capital Advisors Pvt Ltd and the Registrar to the issue is KFin Technologies Ltd.

The company intends to utilize the proceeds of the Issue to meet the following objectives:

  1. Repayment of secured and unsecured loans
  2. Funding the working capital requirements of the company
  3. General Corporate Purposes

JFL Life Sciences Limited is engaged in the business of manufacturing pharmaceutical products. Their product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).With market presence in pan India, products of JFL supplies to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and an FDA approved state of the art manufacturing facility near Ahmedabad.

The Company has registered their products to manufacture in various countries like sovereign of Kenya, Nigeria, Yemen, & Myanmar. Few of their products are also registered with Ukraine, Uzbekistan, and Kazakhstan as well. This builds a moat around their business. This also makes them a ‘one-stop-shop’ service provider for catering to all of the customer’s needs domestically as well as internationally.

The promoters, Mr. Smiral Ashwinbhai Patel and Tejal Smiralbhai Patel are actively involved in the day-to-day business of the company and are the guiding force behind the strategic decisions for the Company. Their management team and other key management personnel are well qualified and have extensive industry expertise, and have been responsible for the operational growth.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

14 thoughts on “JFL Life Sciences Limited files Prospectus with NSE EMERGE

  1. Grossly, this is a subcutaneous mass, firmly fixed around the anal sac that arises from the glands in the wall of these sacs buy cialis online Ninety nine patients 21 were identified as age 75 years in the geriatric subgroup analysis

  2. lasix effect on potassium The laboratory description of acquired resistance forms the scientific basis for the understanding of current therapeutic interventions with aromatase inhibitors or fulvestrant as second line agents, following the development of clinical resistance to tamoxifen

  3. There were no differences between the comparison groups for the critical outcomes addressed persistent high blood pressure two trials, 59 women; RR 1 accutane generic A distinctive subtype affecting armpits, groin and the sides of the neck has been described

  4. S100ОІ protein is a calcium binding protein expressed in Schwann cells in the peripheral nervous system Duobles et al cialis 20 mg These articles focus on the experience of suffering from cancer or of caring for people diagnosed with cancer, and they include narratives, topical essays

Leave a Reply

Your email address will not be published.

Business

On This ‘WORLD CANCER DAY’: 8 Best Oncologists Share Their Advice on Increasing Risks of Cancer.

New Delhi (India), February 4: World Cancer Day is observed worldwide on February 4 every year. It is a global initiative led by the Union for International Cancer Control (UICC) for a cancer-free world. This year’s World Cancer Day theme, “Close the Care Gap”, is all about celebrating progress in its many forms that enable […]

Read More
Business

‘My Company is My Family; My Family is not My Company’, proponent Govindkaka of Shree Ramkrishna Exports Pvt. Ltd honoured with 2022 Hurun Most Respected Family Business of the Year Award

Renowned Diamond Baron, Visionary, Industrialist, and Humanitarian, Shri Govind Dholakia sounds stimulating when he says “Our Company has been made into a Family; We haven’t made our Family into a Company!” Surat (Gujarat) [India], February 4: Shree Ramkrishna Exports Pvt. Ltd. (SRK), a global leader in the world of diamonds is the Most Respected Family […]

Read More
Business

CricAdda and Sanjay Dutt: A winning combination for sports fans and gamers

New Delhi (India), February 4: CricAdda, the online sports and fantasy gaming brand, announced that Indian film actor & renowned celebrity Sanjay Dutt has joined the company as its brand ambassador. The announcement comes as CricAdda looks to expand its reach and appeal to a wider audience of sports fans and gamers. As the brand […]

Read More